Vitrolife AB 2023 IR
The report highlights the Vitrolife Group's performance and sustainability progress for the fiscal year 2023. The company updated its corporate strategy and financial targets, aiming for over 10% annual organic revenue growth and an EBITDA margin above 33%. Vitrolife officially committed to the Science Based Targets initiative (SBTi) to align its emissions with a 1.5°C pathway. Financially, the company achieved net sales of SEK 3,512 million and an EBITDA margin of 32.3%, despite being impacted by a non-cash impairment charge.
Company: Vitrolife AB
Sector: Health Care
Country: Sweden
Year: 2023
Type: IR
Pages: 158
Vitrolife AB
Annual And Sustainability Report
The report highlights the Vitrolife Group's performance and sustainability progress for the fiscal year 2023. The company updated its corporate strategy and financial targets, aiming for over 10% annual organic revenue growth and an EBITDA margin above 33%. Vitrolife officially committed to the Science Based Targets initiative (SBTi) to align its emissions with a 1.5°C pathway. Financially, the company achieved net sales of SEK 3,512 million and an EBITDA margin of 32.3%, despite being impacted by a non-cash impairment charge.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees